2019
DOI: 10.21641/los.15.4.82
|View full text |Cite
|
Sign up to set email alerts
|

Ocena wpływu dawki i mocy promieniowania jonizującego na komórki raka piersi. The assessment of the effect of ionizing radiation dose and dose rate for breast cancer cells

Abstract: Rak piersi jest najczęściej występującym typem nowotworu wśród kobiet. Ze względu na odmienne typy histologiczne guzów, stosuje się różne podejście terapeutyczne. Najczęściej jest to leczenie skojarzone, obejmujące chirurgiczne usunięcie ogniska nowotworowego, radioterapię oraz leczenie cytostatykami. Jednakże, głównym celem każdej stosowanej terapii jest zniszczenie komórek nowotworowych przy odpowiednio niskim uszkodzeniu tkanek  zdrowych. Celem pracy była ocena wpływu stosowanych klinicznie schematów naprom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
(35 reference statements)
0
2
0
Order By: Relevance
“…A clonogenic assay was performed as described elsewhere [ 24 , 25 ]. Briefly, after irradiation, the cells were counted using a Luna II automated cell counter (Logos Biosystems) plated on 6-well plates and incubated for 10–14 days.…”
Section: Methodsmentioning
confidence: 99%
“…A clonogenic assay was performed as described elsewhere [ 24 , 25 ]. Briefly, after irradiation, the cells were counted using a Luna II automated cell counter (Logos Biosystems) plated on 6-well plates and incubated for 10–14 days.…”
Section: Methodsmentioning
confidence: 99%
“…Conventional treatment of cancer includes surgery, chemotherapy, and radiation therapy. Many different factors are used to sensitize cancer cells to ionizing radiation while protecting the percentage of normal cells in the field of the therapeutic beam [39]. Metallic nanoparticles are usually used as agents sensitizing cancer cells to ionizing radiation during radiotherapy [40].…”
Section: Treatmentmentioning
confidence: 99%